2003
DOI: 10.1046/j.1365-4362.2003.01636.x
|View full text |Cite
|
Sign up to set email alerts
|

Kaposi's sarcoma in renal transplant patients: experience at the Cruces Hospital in Bilbao

Abstract: Our experience indicates that a continuous state of immunodeficiency is important for the development of KS in RTRs. The association, previously described between HHV-8 and transplant-associated KS, also exists in the studied population.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2004
2004
2014
2014

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(3 citation statements)
references
References 29 publications
0
3
0
Order By: Relevance
“…This includes (i) Classic KS, a disease that mainly affects elderly Mediterranean men, (ii) iatrogenic KS, which develops in patients taking immunomodulatory agents in the context of solid-organ transplantation, and (iii) AIDS-related KS. (5-7) African-KS is endemic to Africa and unrelated to HIV infection. KSHV infection and an ineffective host immune response towards this gamma herpes virus are common to all of the aforementioned KS clinical subtypes.…”
Section: Major Clinical Characteristicsmentioning
confidence: 99%
“…This includes (i) Classic KS, a disease that mainly affects elderly Mediterranean men, (ii) iatrogenic KS, which develops in patients taking immunomodulatory agents in the context of solid-organ transplantation, and (iii) AIDS-related KS. (5-7) African-KS is endemic to Africa and unrelated to HIV infection. KSHV infection and an ineffective host immune response towards this gamma herpes virus are common to all of the aforementioned KS clinical subtypes.…”
Section: Major Clinical Characteristicsmentioning
confidence: 99%
“…One hundred twenty‐three abstracts were excluded due to one or more of the following characteristics: a pediatric age group, fewer than 100 subjects; and review type article, case series, clinical trials, or studies of therapy or survival after diagnosis of a post‐transplant neoplasm. A total of 64 studies were reviewed in full text and analyzed in more detail (5, 7–69).…”
Section: Resultsmentioning
confidence: 99%
“…The lesion is 400e500 times more common among transplant patients than among the general population, afflicting 1 out of 200 transplant patients in the United States (Harwood et al, 1979). In this group of patients, immunosuppressive therapy plays a major role in the development of the lesion (Mitxelena et al, 2003) that is known as iatrogenic KS (Trattner et al, 1993).…”
Section: Discussionmentioning
confidence: 99%